| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 15 | 2025 | 501 | 3.390 |
Why?
|
| Intellectual Disability | 9 | 2025 | 1054 | 1.380 |
Why?
|
| Developmental Disabilities | 6 | 2025 | 715 | 1.230 |
Why?
|
| Phenotype | 21 | 2025 | 4268 | 1.180 |
Why?
|
| Listeriosis | 3 | 2017 | 20 | 1.120 |
Why?
|
| Listeria monocytogenes | 3 | 2017 | 31 | 1.020 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1283 | 0.950 |
Why?
|
| Membrane Transport Proteins | 2 | 2024 | 174 | 0.890 |
Why?
|
| Apyrase | 1 | 2022 | 19 | 0.780 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 29 | 0.780 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 132 | 0.770 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2023 | 198 | 0.760 |
Why?
|
| Microcephaly | 2 | 2022 | 330 | 0.750 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 9 | 0.750 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 7 | 0.740 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2023 | 101 | 0.730 |
Why?
|
| Peroxisomal Disorders | 1 | 2021 | 13 | 0.730 |
Why?
|
| Achondroplasia | 1 | 2021 | 23 | 0.710 |
Why?
|
| Migraine with Aura | 1 | 2021 | 16 | 0.710 |
Why?
|
| Hemiplegia | 1 | 2021 | 44 | 0.710 |
Why?
|
| White Matter | 2 | 2022 | 184 | 0.690 |
Why?
|
| Membrane Proteins | 3 | 2025 | 1537 | 0.690 |
Why?
|
| Mutation | 10 | 2025 | 5900 | 0.690 |
Why?
|
| Pedigree | 9 | 2025 | 1608 | 0.670 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 80 | 0.670 |
Why?
|
| Genetic Association Studies | 3 | 2025 | 780 | 0.650 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 259 | 0.610 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 384 | 0.610 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 3175 | 0.590 |
Why?
|
| Interferon-beta | 2 | 2017 | 52 | 0.590 |
Why?
|
| Epilepsy | 3 | 2022 | 874 | 0.570 |
Why?
|
| Alleles | 8 | 2025 | 1617 | 0.550 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 577 | 0.540 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.520 |
Why?
|
| Homozygote | 4 | 2024 | 547 | 0.480 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2025 | 44 | 0.480 |
Why?
|
| Nervous System Malformations | 3 | 2022 | 130 | 0.480 |
Why?
|
| Humans | 51 | 2025 | 125331 | 0.450 |
Why?
|
| Spleen | 1 | 2014 | 280 | 0.430 |
Why?
|
| Interferon-alpha | 1 | 2014 | 241 | 0.400 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 163 | 0.400 |
Why?
|
| Genomics | 4 | 2024 | 1520 | 0.390 |
Why?
|
| Animals | 21 | 2025 | 34298 | 0.350 |
Why?
|
| Infant | 13 | 2025 | 12581 | 0.330 |
Why?
|
| Child, Preschool | 13 | 2025 | 14123 | 0.320 |
Why?
|
| Epithelial Cells | 2 | 2011 | 909 | 0.320 |
Why?
|
| Male | 23 | 2025 | 61573 | 0.310 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2011 | 193 | 0.310 |
Why?
|
| Mice | 12 | 2024 | 17736 | 0.300 |
Why?
|
| Child | 15 | 2025 | 24575 | 0.290 |
Why?
|
| Genetic Variation | 4 | 2024 | 1505 | 0.270 |
Why?
|
| Lung Diseases | 1 | 2011 | 384 | 0.270 |
Why?
|
| Mutation, Missense | 4 | 2024 | 879 | 0.270 |
Why?
|
| Haploinsufficiency | 2 | 2025 | 258 | 0.260 |
Why?
|
| Loss of Function Mutation | 2 | 2024 | 150 | 0.260 |
Why?
|
| Complement C5a | 2 | 2017 | 24 | 0.250 |
Why?
|
| Zebrafish | 2 | 2025 | 380 | 0.240 |
Why?
|
| tRNA Methyltransferases | 1 | 2025 | 5 | 0.240 |
Why?
|
| Adolescent | 13 | 2025 | 19419 | 0.240 |
Why?
|
| Mammals | 2 | 2023 | 257 | 0.240 |
Why?
|
| Glucosyltransferases | 1 | 2025 | 49 | 0.240 |
Why?
|
| Arthrogryposis | 1 | 2025 | 35 | 0.230 |
Why?
|
| Ethanolamine | 1 | 2024 | 7 | 0.230 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2021 | 24 | 0.230 |
Why?
|
| RNA, Transfer | 1 | 2025 | 72 | 0.230 |
Why?
|
| Zellweger Syndrome | 1 | 2024 | 15 | 0.230 |
Why?
|
| Polyneuropathies | 1 | 2024 | 29 | 0.230 |
Why?
|
| Drosophila melanogaster | 3 | 2025 | 771 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 62 | 0.230 |
Why?
|
| Choline | 1 | 2024 | 54 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2024 | 119 | 0.220 |
Why?
|
| Receptors, Virus | 1 | 2024 | 108 | 0.220 |
Why?
|
| Vesicular Transport Proteins | 2 | 2024 | 120 | 0.220 |
Why?
|
| Immunity, Innate | 2 | 2017 | 372 | 0.220 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 11 | 0.210 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 45 | 0.210 |
Why?
|
| Drosophila Proteins | 3 | 2025 | 713 | 0.210 |
Why?
|
| Paraparesis, Spastic | 1 | 2023 | 4 | 0.210 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2023 | 100 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 262 | 0.200 |
Why?
|
| Microphthalmos | 1 | 2023 | 60 | 0.200 |
Why?
|
| Cerebellar Ataxia | 1 | 2023 | 66 | 0.200 |
Why?
|
| Myokymia | 1 | 2022 | 8 | 0.200 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 130 | 0.200 |
Why?
|
| Osteoporosis | 1 | 2023 | 117 | 0.200 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 8 | 0.200 |
Why?
|
| Dysarthria | 1 | 2022 | 22 | 0.200 |
Why?
|
| Female | 18 | 2025 | 66836 | 0.200 |
Why?
|
| Translocation, Genetic | 1 | 2024 | 358 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 560 | 0.200 |
Why?
|
| Racemases and Epimerases | 1 | 2022 | 9 | 0.200 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 10 | 0.200 |
Why?
|
| NADP | 1 | 2022 | 52 | 0.190 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 68 | 0.190 |
Why?
|
| NAD | 1 | 2022 | 45 | 0.190 |
Why?
|
| Niacin | 1 | 2022 | 57 | 0.190 |
Why?
|
| Seizures | 3 | 2023 | 871 | 0.190 |
Why?
|
| Paraplegia | 1 | 2022 | 95 | 0.190 |
Why?
|
| DNA Helicases | 1 | 2023 | 236 | 0.190 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 107 | 0.180 |
Why?
|
| Chromosome Aberrations | 1 | 2024 | 620 | 0.180 |
Why?
|
| Young Adult | 4 | 2025 | 9066 | 0.180 |
Why?
|
| Facies | 1 | 2021 | 153 | 0.180 |
Why?
|
| Apnea | 1 | 2021 | 31 | 0.180 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 38 | 0.180 |
Why?
|
| Alternative Splicing | 1 | 2023 | 355 | 0.170 |
Why?
|
| Mediator Complex | 1 | 2021 | 52 | 0.170 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 130 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2023 | 222 | 0.170 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2020 | 2 | 0.170 |
Why?
|
| Proteomics | 1 | 2024 | 507 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2021 | 228 | 0.170 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 57 | 0.170 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 36 | 0.170 |
Why?
|
| Adult | 7 | 2025 | 29607 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 59 | 0.160 |
Why?
|
| Cell Line | 2 | 2023 | 2754 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 238 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 193 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 129 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 52 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2022 | 208 | 0.160 |
Why?
|
| Software | 1 | 2024 | 687 | 0.160 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 150 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 681 | 0.160 |
Why?
|
| Dystonia | 1 | 2021 | 171 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 679 | 0.150 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 963 | 0.150 |
Why?
|
| Calcinosis | 1 | 2020 | 179 | 0.150 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2023 | 399 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2021 | 341 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 1763 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2025 | 690 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2024 | 1013 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 249 | 0.140 |
Why?
|
| Complement C3a | 1 | 2017 | 19 | 0.140 |
Why?
|
| Cerebellum | 1 | 2021 | 439 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2020 | 300 | 0.140 |
Why?
|
| Complement Activation | 1 | 2016 | 52 | 0.130 |
Why?
|
| Syndrome | 3 | 2023 | 1122 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1127 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 375 | 0.130 |
Why?
|
| Liver Transplantation | 1 | 2024 | 1042 | 0.130 |
Why?
|
| Interferon Type I | 1 | 2016 | 107 | 0.120 |
Why?
|
| Echocardiography | 1 | 2021 | 1060 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2021 | 976 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 89 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 933 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 945 | 0.120 |
Why?
|
| Drosophila | 3 | 2025 | 776 | 0.120 |
Why?
|
| Anaphylatoxins | 1 | 2014 | 1 | 0.120 |
Why?
|
| Complement C5b | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2014 | 12 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3751 | 0.120 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 23 | 0.120 |
Why?
|
| Receptors, Interferon | 1 | 2014 | 25 | 0.120 |
Why?
|
| Bacterial Load | 1 | 2014 | 30 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 2059 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 132 | 0.110 |
Why?
|
| Glycosylation | 2 | 2025 | 124 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 253 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1316 | 0.110 |
Why?
|
| Antibodies | 1 | 2014 | 374 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2023 | 2602 | 0.100 |
Why?
|
| Apoptosis | 2 | 2022 | 1816 | 0.100 |
Why?
|
| Muscle Hypotonia | 2 | 2025 | 187 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2014 | 408 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2249 | 0.100 |
Why?
|
| Neurons | 1 | 2022 | 1941 | 0.100 |
Why?
|
| Rare Diseases | 2 | 2024 | 190 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2014 | 1493 | 0.090 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 31 | 0.090 |
Why?
|
| Gene Expression | 1 | 2014 | 1553 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 276 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2023 | 738 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 63 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 134 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2011 | 173 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3603 | 0.080 |
Why?
|
| Liver | 1 | 2014 | 1748 | 0.070 |
Why?
|
| Interleukin-9 | 1 | 2006 | 4 | 0.070 |
Why?
|
| Disease Progression | 2 | 2023 | 2081 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 213 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2025 | 80 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2017 | 4591 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2006 | 137 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3725 | 0.060 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 217 | 0.060 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 15 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 122 | 0.050 |
Why?
|
| Ion Channels | 1 | 2025 | 189 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 98 | 0.050 |
Why?
|
| Carcinoma | 1 | 2006 | 290 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 39 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 126 | 0.050 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 55 | 0.050 |
Why?
|
| Retinoids | 1 | 2023 | 34 | 0.050 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2023 | 98 | 0.050 |
Why?
|
| Alopecia | 1 | 2023 | 39 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2022 | 10 | 0.050 |
Why?
|
| Lung | 1 | 2011 | 1487 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2023 | 49 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2023 | 73 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 24 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2023 | 238 | 0.050 |
Why?
|
| Guanosine | 1 | 2022 | 11 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 298 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 244 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2022 | 33 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 22 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 141 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2023 | 404 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2022 | 95 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2022 | 54 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 4837 | 0.050 |
Why?
|
| Turkey | 1 | 2021 | 63 | 0.050 |
Why?
|
| Calpain | 1 | 2021 | 40 | 0.050 |
Why?
|
| Atrophy | 1 | 2022 | 231 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2022 | 85 | 0.050 |
Why?
|
| Actins | 1 | 2023 | 345 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2023 | 806 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 439 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2022 | 172 | 0.040 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 5 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.040 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 23 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2020 | 92 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 358 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 52 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 559 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 26 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 18 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 163 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 61 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 26 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2024 | 367 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 359 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 237 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 45 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 70 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 146 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 152 | 0.040 |
Why?
|
| Axons | 1 | 2022 | 369 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 434 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1034 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 357 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 533 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 887 | 0.040 |
Why?
|
| Microglia | 1 | 2020 | 102 | 0.040 |
Why?
|
| Genotype | 1 | 2025 | 2569 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 413 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 256 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 1980 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 170 | 0.040 |
Why?
|
| Cataract | 1 | 2021 | 223 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8259 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 252 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3309 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 306 | 0.040 |
Why?
|
| Genome, Human | 1 | 2024 | 1293 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 377 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 521 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2715 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2017 | 247 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3431 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2810 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 510 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 625 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 886 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 822 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2466 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1109 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 3009 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10287 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 335 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 233 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 4418 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 1076 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 19728 | 0.020 |
Why?
|
| Janus Kinase 3 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4405 | 0.020 |
Why?
|
| Oxygen | 1 | 2010 | 556 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1338 | 0.020 |
Why?
|
| G1 Phase | 1 | 2006 | 67 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 129 | 0.020 |
Why?
|
| Cell Survival | 1 | 2006 | 819 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16344 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2371 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1907 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 26807 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 2412 | 0.010 |
Why?
|